Economic costs and medications for diabetes in older patients in Beijing, China: electronic insurance data analysis
Diabetes management in older patients faces challenges due to extensive variability. Medication analysis in this study found that the current situation of comprehensive control of diabetes in elderly patients is worrying, and the complexity of their medication is still on the increasing trend. It is important to select more appropriate antiglycemic drugs to economically benefit the patients and to control the progression of complications.
Authors
- Mingqun Deng (ORCID: https://orcid.org/0000-0002-7808-5361)
- Jingtao Qiao
- Lixin Guo (ORCID: https://orcid.org/0000-0001-6863-1798)
- Ran Wei (ORCID: https://orcid.org/0000-0003-4293-6686)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-1397-5224)
- Yanhua Ma
- Weihao Wang (ORCID: https://orcid.org/0000-0002-5896-2793)
- Yu Yang (ORCID: https://orcid.org/0000-0002-5611-8951)
- Qi Pan (ORCID: https://orcid.org/0000-0003-2543-2937)
- Lina Zhang (ORCID: https://orcid.org/0000-0002-8214-8505)
- Yan Zhao (ORCID: https://orcid.org/0000-0002-5761-7808)
- Jingyi Luo (ORCID: https://orcid.org/0000-0002-4361-3515)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fphar.2025.1549244
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bethune Charitable Foundation
- National Natural Science Foundation of China